Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133621) titled 'Clinical efficacy study on personalized corneal stromal ablation guided by topographic map combined with rapid corneal collagen cross-linking in the treatment of keratoconus' on Sept. 29.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Xi'an NO.1 Hospital
Condition:
Keratoconus
Intervention:
CXL (corneal collagen cross-linking):N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: CXL (corneal collagen cross-linking):15;T-CAT (topography-guided customized ablation with corneal collagen cross-linking):15;
Countrie...